Dale Broadrick
CIK: 0001677513
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BRTX
BioRestorative Therapies, Inc.
10% Owner
Discretionary Trading P&L
Holdings
About Broadrick Dale
Broadrick Dale (SEC CIK 0001677513) files insider reports with the SEC as 10% Owner of BioRestorative Therapies, Inc. (BRTX).
Signal8 holds 1 ownership filing by Broadrick Dale, a Form 4, filed on Nov 5, 2024. Those filings report 1 transaction, the latest on Oct 28, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Broadrick Dale's filings is in NASHVILLE, TN.
Recent filings by Broadrick Dale
- Oct 28, 2024: Open-market sale of BRTX shares (Form 4, code S).
Other insiders filing for BioRestorative Therapies, Inc. (BRTX)
- Randhawa Esha, Director
- Grasso Mika, Director
- Dhaliwal Jatinder, Director
- Field Katharyn, Director
- Silva Francisco, VP of Research and Development
- ALSTODT LANCE, President, CEO, COB